Active HIV-1 redistribution and replication in the brain with HIV encephalitis

被引:25
作者
Gatanaga, H
Oka, S
Ida, S
Wakabayashi, T
Shioda, T
Iwamoto, A
机构
[1] Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan
[2] Univ Tokyo, Inst Med Sci, Dept Infect Dis, Tokyo, Japan
[3] Univ Tokyo, Inst Med Sci, Dept Lab Med, Tokyo, Japan
关键词
D O I
10.1007/s007050050483
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The central nervous system (CNS) is of particular importance in human immunodeficiency virus type 1 (HIV-1) infection. First, the CNS may be difficult to access for anti-retroviral treatment and may become a sanctuary for residual viruses. Second, HIV-1 infection may lead to AIDS dementia complex (ADC) culminating in HIV-1 encephalitis. In order to examine the pattern of drug resistance and the role of encephalitis in enhancing viral redistribution to the CNS, we compared pol gene quasispecies of the spleen and brain in two patients with and two patients without HIV-1 encephalitis, who had been treated with zidovudine (AZT). Although a variable degree of AZT resistance was noted in both the spleen and brain of all patients, phylogenetic analysis indicated that quasispecies developed rather independently in the systemic circulation (spleen) and CNS (brain) of patients without HIV-1 encephalitis, while similar pol gene sequences were obtained from the two compartments of patients with HIV-1 encephalitis. env gene V3 region of patients with HIV-1 encephalitis showed distinct quasispecies in the spleen and brain. Our results suggest that HIV-1 redistribution to CNS is more active in cases with encephalitis and that HIV-1 distributed late to CNS grow actively under certain selective pressure exerted on the V3 region of the env gene.
引用
收藏
页码:29 / 43
页数:15
相关论文
共 37 条
  • [1] Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry
    Bagasra, O
    Lavi, E
    Bobroski, L
    Khalili, K
    Pestaner, JP
    Tawadros, R
    Pomerantz, RJ
    [J]. AIDS, 1996, 10 (06) : 573 - 585
  • [2] ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS
    BOUCHER, CAB
    OSULLIVAN, E
    MULDER, JW
    RAMAUTARSING, C
    KELLAM, P
    DARBY, G
    LANGE, JMA
    GOUDSMIT, J
    LARDER, BA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) : 105 - 110
  • [3] Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patients
    Cleland, A
    Watson, HG
    Robertson, P
    Ludlam, CA
    Brown, AJL
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (01): : 6 - 18
  • [4] REVERSE-TRANSCRIPTASE SEQUENCE OF PAIRED ISOLATES OF CEREBROSPINAL-FLUID AND BLOOD FROM PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DURING ZIDOVUDINE TREATMENT
    DISTEFANO, M
    SABRI, F
    LEITNER, T
    SVENNERHOLM, B
    HAGBERG, L
    NORKRANS, G
    CHIODI, F
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) : 352 - 355
  • [5] DiStefano M, 1996, J MED VIROL, V49, P41, DOI 10.1002/(SICI)1096-9071(199605)49:1&lt
  • [6] 41::AID-JMV7&gt
  • [7] 3.0.CO
  • [8] 2-K
  • [9] A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
    Doranz, BJ
    Rucker, J
    Yi, YJ
    Smyth, RJ
    Samson, M
    Peiper, SC
    Parmentier, M
    Collman, RG
    Doms, RW
    [J]. CELL, 1996, 85 (07) : 1149 - 1158
  • [10] EMMELKAMP P, 1993, CLIN PSYCHOL PSYCHOT, V1, P1